世界の双極性障害治療市場規模・現状・予測2021-2027

【英語タイトル】Global Bipolar Disorders and Treatment Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR0855)・商品コード:QY21APR0855
・発行会社(調査会社):QYResearch
・発行日:2021年4月(※2024年版があります。お問い合わせください)
・ページ数:95
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、双極性障害治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(気分安定薬、抗けいれん薬、抗精神病薬、抗うつ薬、抗不安薬)、用途別市場規模(病院、薬局、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・双極性障害治療の市場動向
・企業の競争状況、市場シェア
・双極性障害治療の種類別市場規模(気分安定薬、抗けいれん薬、抗精神病薬、抗うつ薬、抗不安薬)
・双極性障害治療の用途別市場規模(病院、薬局、その他)
・双極性障害治療の北米市場規模2016-2027(アメリカ、カナダ)
・双極性障害治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・双極性障害治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・双極性障害治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・双極性障害治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(GlaxoSmithKline、Pfizer、Janssen Pharmaceuticals、Eli Lilly、Allergan、Novartis、​​AbbVie、Otsuka Holdings、AstraZeneca)
・結論
【レポートの概要】

Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks.

Market Analysis and Insights: Global Bipolar Disorders and Treatment Market
The global Bipolar Disorders and Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bipolar Disorders and Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bipolar Disorders and Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bipolar Disorders and Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bipolar Disorders and Treatment market.

Global Bipolar Disorders and Treatment Scope and Market Size
Bipolar Disorders and Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bipolar Disorders and Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Mood stabilizer
Anticonvulsant
Antipsychotic
Antidepressant
Antianxiety

Segment by Application
Hospital
Pharmacy
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline
Pfizer
Janssen Pharmaceuticals
Eli Lilly
Allergan
Novartis
​​AbbVie
Otsuka Holdings
AstraZeneca

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bipolar Disorders and Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Mood stabilizer
1.2.3 Anticonvulsant
1.2.4 Antipsychotic
1.2.5 Antidepressant
1.2.6 Antianxiety
1.3 Market by Application
1.3.1 Global Bipolar Disorders and Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Bipolar Disorders and Treatment Market Perspective (2016-2027)
2.2 Bipolar Disorders and Treatment Growth Trends by Regions
2.2.1 Bipolar Disorders and Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bipolar Disorders and Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Bipolar Disorders and Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Bipolar Disorders and Treatment Industry Dynamic
2.3.1 Bipolar Disorders and Treatment Market Trends
2.3.2 Bipolar Disorders and Treatment Market Drivers
2.3.3 Bipolar Disorders and Treatment Market Challenges
2.3.4 Bipolar Disorders and Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Bipolar Disorders and Treatment Players by Revenue
3.1.1 Global Top Bipolar Disorders and Treatment Players by Revenue (2016-2021)
3.1.2 Global Bipolar Disorders and Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Bipolar Disorders and Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bipolar Disorders and Treatment Revenue
3.4 Global Bipolar Disorders and Treatment Market Concentration Ratio
3.4.1 Global Bipolar Disorders and Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bipolar Disorders and Treatment Revenue in 2020
3.5 Bipolar Disorders and Treatment Key Players Head office and Area Served
3.6 Key Players Bipolar Disorders and Treatment Product Solution and Service
3.7 Date of Enter into Bipolar Disorders and Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Bipolar Disorders and Treatment Breakdown Data by Type
4.1 Global Bipolar Disorders and Treatment Historic Market Size by Type (2016-2021)
4.2 Global Bipolar Disorders and Treatment Forecasted Market Size by Type (2022-2027)

5 Bipolar Disorders and Treatment Breakdown Data by Application
5.1 Global Bipolar Disorders and Treatment Historic Market Size by Application (2016-2021)
5.2 Global Bipolar Disorders and Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Bipolar Disorders and Treatment Market Size (2016-2027)
6.2 North America Bipolar Disorders and Treatment Market Size by Type
6.2.1 North America Bipolar Disorders and Treatment Market Size by Type (2016-2021)
6.2.2 North America Bipolar Disorders and Treatment Market Size by Type (2022-2027)
6.2.3 North America Bipolar Disorders and Treatment Market Size by Type (2016-2027)
6.3 North America Bipolar Disorders and Treatment Market Size by Application
6.3.1 North America Bipolar Disorders and Treatment Market Size by Application (2016-2021)
6.3.2 North America Bipolar Disorders and Treatment Market Size by Application (2022-2027)
6.3.3 North America Bipolar Disorders and Treatment Market Size by Application (2016-2027)
6.4 North America Bipolar Disorders and Treatment Market Size by Country
6.4.1 North America Bipolar Disorders and Treatment Market Size by Country (2016-2021)
6.4.2 North America Bipolar Disorders and Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Bipolar Disorders and Treatment Market Size (2016-2027)
7.2 Europe Bipolar Disorders and Treatment Market Size by Type
7.2.1 Europe Bipolar Disorders and Treatment Market Size by Type (2016-2021)
7.2.2 Europe Bipolar Disorders and Treatment Market Size by Type (2022-2027)
7.2.3 Europe Bipolar Disorders and Treatment Market Size by Type (2016-2027)
7.3 Europe Bipolar Disorders and Treatment Market Size by Application
7.3.1 Europe Bipolar Disorders and Treatment Market Size by Application (2016-2021)
7.3.2 Europe Bipolar Disorders and Treatment Market Size by Application (2022-2027)
7.3.3 Europe Bipolar Disorders and Treatment Market Size by Application (2016-2027)
7.4 Europe Bipolar Disorders and Treatment Market Size by Country
7.4.1 Europe Bipolar Disorders and Treatment Market Size by Country (2016-2021)
7.4.2 Europe Bipolar Disorders and Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Bipolar Disorders and Treatment Market Size (2016-2027)
8.2 Asia-Pacific Bipolar Disorders and Treatment Market Size by Type
8.2.1 Asia-Pacific Bipolar Disorders and Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bipolar Disorders and Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bipolar Disorders and Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Bipolar Disorders and Treatment Market Size by Application
8.3.1 Asia-Pacific Bipolar Disorders and Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bipolar Disorders and Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bipolar Disorders and Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Bipolar Disorders and Treatment Market Size by Region
8.4.1 Asia-Pacific Bipolar Disorders and Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bipolar Disorders and Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Bipolar Disorders and Treatment Market Size (2016-2027)
9.2 Latin America Bipolar Disorders and Treatment Market Size by Type
9.2.1 Latin America Bipolar Disorders and Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Bipolar Disorders and Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Bipolar Disorders and Treatment Market Size by Type (2016-2027)
9.3 Latin America Bipolar Disorders and Treatment Market Size by Application
9.3.1 Latin America Bipolar Disorders and Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Bipolar Disorders and Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Bipolar Disorders and Treatment Market Size by Application (2016-2027)
9.4 Latin America Bipolar Disorders and Treatment Market Size by Country
9.4.1 Latin America Bipolar Disorders and Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Bipolar Disorders and Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Bipolar Disorders and Treatment Market Size (2016-2027)
10.2 Middle East & Africa Bipolar Disorders and Treatment Market Size by Type
10.2.1 Middle East & Africa Bipolar Disorders and Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bipolar Disorders and Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bipolar Disorders and Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Bipolar Disorders and Treatment Market Size by Application
10.3.1 Middle East & Africa Bipolar Disorders and Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bipolar Disorders and Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bipolar Disorders and Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Bipolar Disorders and Treatment Market Size by Country
10.4.1 Middle East & Africa Bipolar Disorders and Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bipolar Disorders and Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Bipolar Disorders and Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Bipolar Disorders and Treatment Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Bipolar Disorders and Treatment Introduction
11.2.4 Pfizer Revenue in Bipolar Disorders and Treatment Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Janssen Pharmaceuticals
11.3.1 Janssen Pharmaceuticals Company Details
11.3.2 Janssen Pharmaceuticals Business Overview
11.3.3 Janssen Pharmaceuticals Bipolar Disorders and Treatment Introduction
11.3.4 Janssen Pharmaceuticals Revenue in Bipolar Disorders and Treatment Business (2016-2021)
11.3.5 Janssen Pharmaceuticals Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Bipolar Disorders and Treatment Introduction
11.4.4 Eli Lilly Revenue in Bipolar Disorders and Treatment Business (2016-2021)
11.4.5 Eli Lilly Recent Development
11.5 Allergan
11.5.1 Allergan Company Details
11.5.2 Allergan Business Overview
11.5.3 Allergan Bipolar Disorders and Treatment Introduction
11.5.4 Allergan Revenue in Bipolar Disorders and Treatment Business (2016-2021)
11.5.5 Allergan Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Bipolar Disorders and Treatment Introduction
11.6.4 Novartis Revenue in Bipolar Disorders and Treatment Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 ​​AbbVie
11.7.1 ​​AbbVie Company Details
11.7.2 ​​AbbVie Business Overview
11.7.3 ​​AbbVie Bipolar Disorders and Treatment Introduction
11.7.4 ​​AbbVie Revenue in Bipolar Disorders and Treatment Business (2016-2021)
11.7.5 ​​AbbVie Recent Development
11.8 Otsuka Holdings
11.8.1 Otsuka Holdings Company Details
11.8.2 Otsuka Holdings Business Overview
11.8.3 Otsuka Holdings Bipolar Disorders and Treatment Introduction
11.8.4 Otsuka Holdings Revenue in Bipolar Disorders and Treatment Business (2016-2021)
11.8.5 Otsuka Holdings Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Bipolar Disorders and Treatment Introduction
11.9.4 AstraZeneca Revenue in Bipolar Disorders and Treatment Business (2016-2021)
11.9.5 AstraZeneca Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Bipolar Disorders and Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Mood stabilizer
Table 3. Key Players of Anticonvulsant
Table 4. Key Players of Antipsychotic
Table 5. Key Players of Antidepressant
Table 6. Key Players of Antianxiety
Table 7. Global Bipolar Disorders and Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Bipolar Disorders and Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Bipolar Disorders and Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Bipolar Disorders and Treatment Market Share by Regions (2016-2021)
Table 11. Global Bipolar Disorders and Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Bipolar Disorders and Treatment Market Share by Regions (2022-2027)
Table 13. Bipolar Disorders and Treatment Market Trends
Table 14. Bipolar Disorders and Treatment Market Drivers
Table 15. Bipolar Disorders and Treatment Market Challenges
Table 16. Bipolar Disorders and Treatment Market Restraints
Table 17. Global Bipolar Disorders and Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Bipolar Disorders and Treatment Market Share by Players (2016-2021)
Table 19. Global Top Bipolar Disorders and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bipolar Disorders and Treatment as of 2020)
Table 20. Ranking of Global Top Bipolar Disorders and Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Bipolar Disorders and Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Bipolar Disorders and Treatment Product Solution and Service
Table 24. Date of Enter into Bipolar Disorders and Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Bipolar Disorders and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Bipolar Disorders and Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Bipolar Disorders and Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Bipolar Disorders and Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Bipolar Disorders and Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Bipolar Disorders and Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Bipolar Disorders and Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Bipolar Disorders and Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Bipolar Disorders and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Bipolar Disorders and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Bipolar Disorders and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Bipolar Disorders and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Bipolar Disorders and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Bipolar Disorders and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Bipolar Disorders and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Bipolar Disorders and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Bipolar Disorders and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Bipolar Disorders and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Bipolar Disorders and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Bipolar Disorders and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Bipolar Disorders and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Bipolar Disorders and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Bipolar Disorders and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Bipolar Disorders and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Bipolar Disorders and Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Bipolar Disorders and Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Bipolar Disorders and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Bipolar Disorders and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Bipolar Disorders and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Bipolar Disorders and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Bipolar Disorders and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Bipolar Disorders and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Bipolar Disorders and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Bipolar Disorders and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Bipolar Disorders and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Bipolar Disorders and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Bipolar Disorders and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Bipolar Disorders and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. GlaxoSmithKline Company Details
Table 65. GlaxoSmithKline Business Overview
Table 66. GlaxoSmithKline Bipolar Disorders and Treatment Product
Table 67. GlaxoSmithKline Revenue in Bipolar Disorders and Treatment Business (2016-2021) & (US$ Million)
Table 68. GlaxoSmithKline Recent Development
Table 69. Pfizer Company Details
Table 70. Pfizer Business Overview
Table 71. Pfizer Bipolar Disorders and Treatment Product
Table 72. Pfizer Revenue in Bipolar Disorders and Treatment Business (2016-2021) & (US$ Million)
Table 73. Pfizer Recent Development
Table 74. Janssen Pharmaceuticals Company Details
Table 75. Janssen Pharmaceuticals Business Overview
Table 76. Janssen Pharmaceuticals Bipolar Disorders and Treatment Product
Table 77. Janssen Pharmaceuticals Revenue in Bipolar Disorders and Treatment Business (2016-2021) & (US$ Million)
Table 78. Janssen Pharmaceuticals Recent Development
Table 79. Eli Lilly Company Details
Table 80. Eli Lilly Business Overview
Table 81. Eli Lilly Bipolar Disorders and Treatment Product
Table 82. Eli Lilly Revenue in Bipolar Disorders and Treatment Business (2016-2021) & (US$ Million)
Table 83. Eli Lilly Recent Development
Table 84. Allergan Company Details
Table 85. Allergan Business Overview
Table 86. Allergan Bipolar Disorders and Treatment Product
Table 87. Allergan Revenue in Bipolar Disorders and Treatment Business (2016-2021) & (US$ Million)
Table 88. Allergan Recent Development
Table 89. Novartis Company Details
Table 90. Novartis Business Overview
Table 91. Novartis Bipolar Disorders and Treatment Product
Table 92. Novartis Revenue in Bipolar Disorders and Treatment Business (2016-2021) & (US$ Million)
Table 93. Novartis Recent Development
Table 94. ​​AbbVie Company Details
Table 95. ​​AbbVie Business Overview
Table 96. ​​AbbVie Bipolar Disorders and Treatment Product
Table 97. ​​AbbVie Revenue in Bipolar Disorders and Treatment Business (2016-2021) & (US$ Million)
Table 98. ​​AbbVie Recent Development
Table 99. Otsuka Holdings Company Details
Table 100. Otsuka Holdings Business Overview
Table 101. Otsuka Holdings Revenue in Bipolar Disorders and Treatment Business (2016-2021) & (US$ Million)
Table 102. Otsuka Holdings Recent Development
Table 103. AstraZeneca Company Details
Table 104. AstraZeneca Business Overview
Table 105. AstraZeneca Bipolar Disorders and Treatment Product
Table 106. AstraZeneca Revenue in Bipolar Disorders and Treatment Business (2016-2021) & (US$ Million)
Table 107. AstraZeneca Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bipolar Disorders and Treatment Market Share by Type: 2020 VS 2027
Figure 2. Mood stabilizer Features
Figure 3. Anticonvulsant Features
Figure 4. Antipsychotic Features
Figure 5. Antidepressant Features
Figure 6. Antianxiety Features
Figure 7. Global Bipolar Disorders and Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Pharmacy Case Studies
Figure 10. Other Case Studies
Figure 11. Bipolar Disorders and Treatment Report Years Considered
Figure 12. Global Bipolar Disorders and Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Bipolar Disorders and Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Bipolar Disorders and Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Bipolar Disorders and Treatment Market Share by Regions (2022-2027)
Figure 16. Global Bipolar Disorders and Treatment Market Share by Players in 2020
Figure 17. Global Top Bipolar Disorders and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bipolar Disorders and Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Bipolar Disorders and Treatment Revenue in 2020
Figure 19. Global Bipolar Disorders and Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Bipolar Disorders and Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Bipolar Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Bipolar Disorders and Treatment Market Share by Type (2016-2027)
Figure 23. North America Bipolar Disorders and Treatment Market Share by Application (2016-2027)
Figure 24. North America Bipolar Disorders and Treatment Market Share by Country (2016-2027)
Figure 25. United States Bipolar Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Bipolar Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Bipolar Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Bipolar Disorders and Treatment Market Share by Type (2016-2027)
Figure 29. Europe Bipolar Disorders and Treatment Market Share by Application (2016-2027)
Figure 30. Europe Bipolar Disorders and Treatment Market Share by Country (2016-2027)
Figure 31. Germany Bipolar Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Bipolar Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Bipolar Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Bipolar Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Bipolar Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Bipolar Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Bipolar Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Bipolar Disorders and Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Bipolar Disorders and Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Bipolar Disorders and Treatment Market Share by Region (2016-2027)
Figure 41. China Bipolar Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Bipolar Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Bipolar Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Bipolar Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Bipolar Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Bipolar Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Bipolar Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Bipolar Disorders and Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Bipolar Disorders and Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Bipolar Disorders and Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Bipolar Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Bipolar Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Bipolar Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Bipolar Disorders and Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Bipolar Disorders and Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Bipolar Disorders and Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Bipolar Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Bipolar Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Bipolar Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Bipolar Disorders and Treatment Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Bipolar Disorders and Treatment Business (2016-2021)
Figure 62. Janssen Pharmaceuticals Revenue Growth Rate in Bipolar Disorders and Treatment Business (2016-2021)
Figure 63. Eli Lilly Revenue Growth Rate in Bipolar Disorders and Treatment Business (2016-2021)
Figure 64. Allergan Revenue Growth Rate in Bipolar Disorders and Treatment Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Bipolar Disorders and Treatment Business (2016-2021)
Figure 66. ​​AbbVie Revenue Growth Rate in Bipolar Disorders and Treatment Business (2016-2021)
Figure 67. Otsuka Holdings Revenue Growth Rate in Bipolar Disorders and Treatment Business (2016-2021)
Figure 68. AstraZeneca Revenue Growth Rate in Bipolar Disorders and Treatment Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed


【掲載企業】

GlaxoSmithKline、Pfizer、Janssen Pharmaceuticals、Eli Lilly、Allergan、Novartis、​​AbbVie、Otsuka Holdings、AstraZeneca

★調査レポート[世界の双極性障害治療市場規模・現状・予測2021-2027] (コード:QY21APR0855)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の双極性障害治療市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆